Cargando…

Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Capecitabine-based neoadjuvant chemoradiation therapy (nCRT) is currently the mainstay of treatment for locally advanced rectal cancer (LARC), prior to surgical tumor removal. While response to this treatment is partial, it carries significant risk of side effects. As of today, there is no accepted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasnis, Erez, Dahan, Aviva, Khoury, Wissam, Duek, Daniel, Fisher, Yael, Beny, Alex, Shaked, Yuval, Chowers, Yehuda, Half, Elizabeth E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435035/ https://www.ncbi.nlm.nih.gov/pubmed/32903466 http://dx.doi.org/10.3389/fonc.2020.01375

Ejemplares similares

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
por: Verschoor, Chris P., et al.
Publicado: (2013)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

Volume of fluid consumption during preparation for colonoscopy is possibly the single most important determinant of bowel preparation adequacy
por: Gorelik, Yuri, et al.
Publicado: (2021)

Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy()()
por: Hasnis, Erez, et al.
Publicado: (2014)

Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2019)

Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer
por: Dimitrova, Polina, et al.
Publicado: (2023)

CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset
por: Hassan, Mirhane, et al.
Publicado: (2018)

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
por: Martin, Daniel, et al.
Publicado: (2017)

Gut microbial signatures are associated with Lynch syndrome (LS) and cancer history in Druze communities in Israel
por: Naddaf, Rawi, et al.
Publicado: (2023)

CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
por: Stanchina, Michele, et al.
Publicado: (2019)

Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33
por: Bhattacherjee, Abhishek, et al.
Publicado: (2020)

CD74 and intratumoral immune response in breast cancer
por: Wang, Zhi-Qiang, et al.
Publicado: (2016)

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
por: Ren, Chun-Xia, et al.
Publicado: (2017)

Clinical significance of peripheral blood CD11b(+)/CD33(+)/HLA-DR(-) myeloid cells in infants and children with infectious diseases and increased CRP
por: Latifi, Aysan, et al.
Publicado: (2020)

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
por: Banchereau, Romain, et al.
Publicado: (2021)

Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33(+)CD11b(+)HLA-DR(+) Cells: A Cross-Sectional Study
por: Meng, Zhefeng, et al.
Publicado: (2016)

Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
por: Zhang, Xia, et al.
Publicado: (2020)

Targeting the Membrane-Proximal C2-Set Domain of CD33 for Improved CD33-Directed Immunotherapy
por: Godwin, Colin D., et al.
Publicado: (2021)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors
por: Suhovskih, Anastasia V., et al.
Publicado: (2020)

CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell
por: Wang, Binglin, et al.
Publicado: (2021)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
por: Lubbers, Joyce M., et al.
Publicado: (2022)

Intratumor childhood vaccine-specific CD4(+) T-cell recall coordinates antitumor CD8(+) T cells and eosinophils
por: Brown, Michael C, et al.
Publicado: (2023)

Effect of APOE and CD33 on Cognitive Decline
por: Hayden, Kathleen M., et al.
Publicado: (2015)

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells
por: Roskopf, Claudia C., et al.
Publicado: (2016)

Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19
por: Martínez-Diz, Silvia, et al.
Publicado: (2023)

Intratumoral Convergence of the TCR Repertoires of Effector and Foxp3(+) CD4(+) T cells
por: Kuczma, Michal, et al.
Publicado: (2010)

Expression of HLA-I, CD8, and CD4 and Their Clinical Significance in Cervical Cancer
por: Fan, Jiang Tao, et al.
Publicado: (2011)

Intratumoral CD103(+)CD4(+) T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients
por: Gu, Yun, et al.
Publicado: (2020)

Intratumoral CD103(+)CD8(+) T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma
por: Ren, Siqi, et al.
Publicado: (2023)

Correction: Effect of APOE and CD33 on Cognitive Decline
por: Hayden, Kathleen M., et al.
Publicado: (2015)

Multiple Sclerosis: Shall We Target CD33?
por: Siokas, Vasileios, et al.
Publicado: (2020)

Targeting CD33 for acute myeloid leukemia therapy
por: Liu, Jingjing, et al.
Publicado: (2022)

In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33(+) Acute Myeloid Leukemia
por: Dutour, A., et al.
Publicado: (2012)

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
por: Ehninger, A, et al.
Publicado: (2014)

HLA-DR polymorphism affects the interaction with CD4
Publicado: (1995)

Predicting HLA CD4 Immunogenicity in Human Populations
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rn8fkrtek0nh1sm7otskop6n7